Gentamicin and norfloxacin prophylaxis for transrectal ultrasound-guided prostate biopsy
Healthcare Infection,  Clinical Article

Jeremiah CJ et al. – Transrectal ultrasound guided prostate biopsy (TRUSPB) is the mainstay of diagnosis for prostate cancer. Clinical trials have established that antibiotic prophylaxis is effective in reducing infective complications, but breakthrough bacteraemia has been described with multiresistant organisms. The authors reviewed the rate of bacteraemia and re–admission in patients undergoing TRUSPB. Recent reports of breakthrough bacteraemia suggest that effectiveness of single agent fluoroquinolone or gentamicin prophylaxis may be compromised by increasing rates of resistance. Combination prophylaxis with gentamicin and norfloxacin is associated with a low rate of infective complications.

Methods

  • The Alfred Hospital is a tertiary referral hospital in Melbourne, Australia.
  • The routine antibiotic prophylactic regimen is gentamicin and norfloxacin.
  • Patients undergoing TRUSPB at the Alfred Hospital were linked to databases of blood and urine cultures, and to admissions with infective complications within 14 days.

Results

  • Between June 2007 and July 2010, 459 patients underwent TRUSPB at the Alfred Hospital.
  • No patient (95% CI: 0, 0.8%) had a positive blood culture, and one patient had a positive urine culture (95% CI: 0.04, 1.2%) within 14 days of the procedure.
  • There were two readmissions: a 66 year old man with systemic culture–negative sepsis, and a 54 year old man with a urinary tract infection.
  • In 50 randomly selected patients, all patients received norfloxacin but only 80% of patients received gentamicin.
  • Between 2007 and 2010, 6.0% of isolates were non–susceptible to norfloxacin, 5.8% were non–susceptible to gentamicin and 3.2% were non–susceptible to both gentamicin and norfloxacin.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Urology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Urology Articles

1 Who dies from prostate cancer? Prostate Cancer & Prostatic Diseases, October 17, 2014    Clinical Article

2 Metformin use and prostate cancer risk Full Text European Urology, November 19, 2014    Free full text    Clinical Article

3 Castration-resistant prostate cancer: AUA guideline amendment The Journal of Urology, November 21, 2014    Clinical Guideline

4 Clinical practice guidelines on prostate cancer: A critical appraisal The Journal of Urology, November 6, 2014    Clinical Article

5 Diethylstilboestrol (1 mg) in the management of castration-resistant prostate cancer Urologia Internationalis, October 21, 2014    Clinical Article

6 Impact of family history on prostate cancer mortality in white men undergoing prostate specific antigen based screening The Journal of Urology, November 11, 2014    Clinical Article

7 Prosbiotate: A multicenter, prospective analysis of infectious complications after prostate biopsy The Journal of Urology, November 12, 2014    Clinical Article

8 Current clinical presentation and treatment of localized prostate cancer in the United States The Journal of Urology, November 18, 2014    Clinical Article

9 The use of metformin in patients with prostate cancer and the risk of death Cancer Epidemiology, Biomarkers & Prevention, September 22, 2014    Clinical Article

10 Calcium and phosphorus intake and prostate cancer risk: A 24-y follow-up study American Journal of Clinical Nutrition, November 26, 2014    Clinical Article

11 The efficacy and tolerability of tarafenacin, a new muscarinic acetylcholine receptor M3 antagonist in patients with overactive bladder; randomised, double-blind, placebo-controlled phase 2 study International Journal of Clinical Practice, November 5, 2014    Evidence Based Medicine    Clinical Article

12 Dutasteride and enzalutamide synergistically suppress prostate tumor cell proliferation The Journal of Urology, October 30, 2014    Clinical Article

13 Cardiovascular events associated with androgen deprivation therapy in patients with prostate cancer: A systematic review and meta-analysis World Journal of Urology, November 25, 2014    Clinical Article

14 Efficacy of high-dose palliative radiotherapy for localised, castration-resistant prostate cancer Clinical Oncology, November 17, 2014    Clinical Article

15 Daily aspirin use and prostate cancer–specific mortality in a large cohort of men with nonmetastatic prostate cancer Journal of Clinical Oncology, October 24, 2014    Clinical Article

16 Stereotactic body radiation therapy for prostate cancer: Rational and reasonable Practical Radiation Oncology, November 13, 2014    Clinical Article

17 Magnetic resonance-invisible versus magnetic resonance–visible prostate cancer in active surveillance: A preliminary report on disease outcomes Urology, November 13, 2014

18 Concordance between biopsy and radical prostatectomy specimen gleason score in internal and external pathology facilities Anticancer Research, October 22, 2014    Clinical Article

19 Primary gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy Full Text European Urology, November 24, 2014    Free full text    Clinical Article

20 A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies Full Text European Urology, November 20, 2014    Free full text    Evidence Based Medicine

Indexed Journals in Urology: Urology, Journal of Urology, European Urology, The Prostatemore